Mirion (MIR) Q2 Revenue Up 8%
Mirion Technologies (NYSE:MIR), a leader in radiation detection and measurement for the nuclear energy and medical sectors, reported its second-quarter earnings on July 31, 2025. The main headline: the company posted GAAP revenue of $222.9 million for Q2 2025, surpassing analyst forecasts of $216.2 million (GAAP) revenue, and achieved adjusted earnings per share (EPS) of $0.11, also beating the $0.10 consensus adjusted EPS estimate. The quarter saw year-over-year growth in both GAAP revenue and GAAP net income, as Mirion also swung to a GAAP net profit. It raised its outlook for total revenue and profit (Adjusted EBITDA and Adjusted EPS, non-GAAP) for fiscal year 2025, though management trimmed expectations for organic revenue growth to approximately 5.0%–7.0% due to headwinds in select submarkets. All in, the period showed continued progress towards Mirion’s longer-term goals, with positive cash flow and strong positions in core markets even as the company faced some challenges.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Mirion is a specialist in radiation monitoring, protection, and measurement systems. Its products serve nuclear energy plants, research labs, and hospitals that use radiation in cancer diagnosis and treatment. With equipment and software in over 95% of the world's nuclear reactors, according to company disclosures, Mirion is deeply woven into the infrastructure of critical, highly regulated markets.
Source Fool.com
